Tony Zhang has been Awarded an Early Stage K99 Award from the NCI/NIH – MVH Lab
MVH Lab shared a post on X by Yichi (Tony) Zhang, Postdoctoral Fellow in Matthew Vander Heiden’s lab at the Koch Institute in MIT, adding:
“I’m thrilled to share that Tony Zhang, a postdoctoral fellow in my lab at the Koch Institute at MIT, has been awarded an early stage K99 award from the NCI/NIH! He is studying how whole-body metabolism drives cancer cachexia. Please join me in congratulating Tony on this honor!”
Quoting Yichi (Tony) Zhang‘s post:
“Happy to announce that I was awarded a pathway to independence award (K99) from the NCI/NIH today to work on studying whole-body metabolism driving cancer cachexia. None of this would be possible without support from Damon Runyon Cancer Research Foundation and mentorship from Eric N. Olson and mvhlab.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023